TNFSF10 and breast cancer: In previous studies, TRAIL has been combined with SAHA in hepatocellular carcinoma, non-small cell lung cancer, or breast cancer and this showed a large improvement in apoptosis indicating the potential role of epigenetic modification [34,40,41].